๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection
NCT06667063COVID-19, Influenza
Zhongnan Hospital
Observational
130
Wuhan
2024-09-19
Recruiting
A Study on the Preference of Risperidone Dosage Forms
NCT06657430Schizophrenia, Bipolar Affective Disorder, Autism Spectrum Disorder, Conduct Disorder
Shanghai Mental Health Center
Observational
1,000
Shanghai
2024-09-19
Recruiting
Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints
NCT06616571Chemotherapy-Induced Febrile Neutropenia
Qilu Pharmaceutical Co., Ltd.
Phase 4
336
Jinan
2024-09-19
Recruiting
Critical State of "Remission-Recurrence" of Ulcerative Colitis
NCT06694883Ulcerative Colitis
Beijing Hospital of Traditional Chinese Medicine
Observational
100
Dongcheng
2024-09-19
Recruiting
Cadonilimab Combined With S-1 or Capecitabine as Second-line Treatment for Advanced Pancreatic Cancer
NCT06532617Pancreatic Neoplasms
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2
30
Shanghai
2024-09-19
Recruiting
Outcomes and Risk Factors of Different Treatment Strategies for Neuro-co-cardiological Diseases and Post-cardiac Surgery Cerebrovascular Diseases
NCT07012668Neuro-co-cardiological Diseases, Post-cardiac Surgery Cerebrovascular Diseases, Vascular Lesion
Beijing Anzhen Hospital
Observational
2,000
Beijing
2024-09-19
Recruiting
A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.
NCT06927466Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
Phase 1
33
Beijing, Nanchang, Shanghai, Suzhou, Wuhan, Xuzhou
2024-09-19
Not yet open
Preoperative (Chemo)Radiotherapy for Locally Recurrent Rectal Cancer
NCT06617052Locally Recurrent Rectal Cancer, Preoperative Chemoradiotherapy
Sixth Affiliated Hospital, Sun Yat-sen University
Observational
100
Guangzhou
2024-09-19
Recruiting
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
NCT06635148Geographic Atrophy, Macular Degeneration
Janssen Research & Development, LLC
Phase 2/3
274
Beijing, Chengdu, Shanghai
2024-09-19
Recruiting
Dyadic Sport Stacking Program for Mild Dementia and Their Family Caregivers
NCT06597981Dementia, Family Caregivers, Dyadic Intervention, Health Related Quality of Life
The University of Hong Kong
Not applicable
144
Chongqing
2024-09-19
Active, closed
A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic Neuropathy (LHON) Associated With ND4 Mutation
NCT07406854Leber Hereditary Optic Neuropathy (LHON)
Wuhan Neurophth Biotechnology Limited Company
Phase 3
95
Beijing
2024-09-19
By invitation
Comparative Study of Perioperative Cardiac Injury in Patients With Functional Adrenal Tumors
NCT07182175Primary Aldosteronism, Adrenal Tumor, Cushing s Syndrome, Pheochromocytoma/Paraganglioma (PPGL)
Peking University First Hospital
Observational
150
Beijing
2024-09-19
Recruiting
Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis
NCT06554509Prurigo Nodularis
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 2/3
423
Beijing
2024-09-19
Active, closed
A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps
NCT06516302Chronic Rhinosinusitis With Nasal Polyps
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Phase 3
228
Beijing
2024-09-19
Active, closed
Analysis of Predictive Factors for Urinary Leakage After Partial Nephrectomy for Renal Hilum Tumors
NCT06916910Partial Nephrectomy, Renal Hilum Tumors, Urinary Leakage
First Affiliated Hospital of Fujian Medical University
Observational
200
Fuzhou
2024-09-18
Recruiting
Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)
NCT06726421Renal Cell Carcinoma (Kidney Cancer), Kidney Cancer Metastatic, Renal Cell Carcinoma Metastatic
Sun Yat-sen University
Phase 3
252
Fuzhou, Guangzhou, Wuhan, Changchun, Chengdu, Wenzhou, Beijing, Shanghai
2024-09-18
Active, closed
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis
NCT06558279Myasthenia Gravis, Ocular
argenx
Phase 3
141
Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Jinan, Nanchang, Shanghai
2024-09-18
By invitation
Hematoporphyrin Photodynamic Therapy for Esophageal Cancer
NCT06437288Esophageal Cancer, Photodynamic Therapy
Sun Yat-sen University
Phase 4
198
Guangzhou
2024-09-18
Recruiting
Impact of Mindful Eating and Movement on University Students' Food and Physical Literacy, and Social-Emotional Competencies
NCT06540898Healthy
University of Macau
Not applicable
144
2024-09-18
Recruiting
Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients๏ผˆPRECISION๏ผ‰
NCT06711432Tumor, Stroke
Zhejiang Cancer Hospital
Not applicable
214
Hangzhou
2024-09-18
Recruiting
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.
NCT06542250B-cell Malignancies
AstraZeneca
Phase 1/2
174
Hangzhou, Shanghai
2024-09-18
Active, closed
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
NCT06559163Systemic Lupus Erythematosus
Zenas BioPharma (USA), LLC
Phase 2
190
Hefei, Beijing, Guangzhou, Shenzhen, Shijiazhuang, Nanchang, Pudong, Shanghai
2024-09-17
Recruiting
Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
NCT06567015Non-small Cell Lung Cancer (NSCLC)
Pierre Fabre Medicament
Phase 1/2
171
Shanghai, Tianjin
2024-09-17
By invitation
A Study on Evaluating the Safety of HST101 in Healthy Chinese Participants
NCT06504043Hypercholesterolemia, Healthy Volunteers, LDL-Cholesterol
Hasten Biopharmaceutical Co., Ltd.
Phase 1
30
Chengdu
2024-09-17
Active, closed
A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
NCT06589986Moderately to Severely Active Ulcerative Colitis
Hoffmann-La Roche
Phase 3
400
Beijing, Binzhou, Changchun, Chengdu, Fuzhou, Guangzhou, Hefei, Huizhou
2024-09-17
Active, closed
A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy
NCT06537999Multifocal Motor Neuropathy
Dianthus Therapeutics
Phase 2
46
Beijing, Shanghai
2024-09-17
Active, closed
Anvumetostat Alone or in Combination With Other Therapies in Subjects With Advanced Thoracic Tumors With Homozygous MTAP-deletion (Master Protocol) (MTAPESTRY 104).
NCT06333951Thoracic Tumors, Non-small Cell Lung Cancer
Amgen
Phase 1
49
Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changchun, Chengdu, Beijing
2024-09-17
Recruiting
HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC
NCT06632093BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Hepatic Arterial Infusion Chemotherapy, Lenvatinib
First Hospital of China Medical University
Observational
84
Shenyang
2024-09-16
By invitation
An Immunity Persistence Study of Booster Dose of Live Attenuated Varicella Vaccine
NCT06484686Varicella
Sinovac (Dalian) Vaccine Technology Co., Ltd.
Phase 4
414
Zhengzhou
2024-09-16
Recruiting
A Trial of Chinese Traditional Medicine Combining With Intradermal Acupuncture for Treating Precocious Puberty
NCT06510764Precocious Puberty, Treatment, Alternative Medicine, Acupuncture
Children's Hospital of Fudan University
Phase 3
170
Shanghai
2024-09-15
By invitation
Multicenter Application of the Intraoperative Hypothermia Risk Prediction Scale and the Distribution of Risk Factor Characteristics in Surgical Patients
NCT06836245Hypothermia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
5,000
Wuhan
2024-09-15
Recruiting
Efficacy and Safety of Fospropofol in Adult Laparoscopic Surgery: A Clinical Trial
NCT06573489Drug Safety
Hui Xu
Phase 4
373
Wuhan
2024-09-15
Recruiting
Blood DdPCR for Early Identification and Dynamic Surveillance of Pathogenic Bacteria in ICU Septic Patients: a Single-centre, Prospective, Observational Study
NCT06791889Sepsis, Bloodstream Infections, Critically Ill Intensive Care Unit Patients
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
60
Wuhan
2024-09-15
Active, closed
Evaluation on Visual Outcome of TMS
NCT06612190Visual Impairment
Evidence Based Cataract Study Group
Not applicable
300
Shanghai
2024-09-15
Not yet open
Bronchoscopic Cryoablation Combined With Chemo-Immunotherapy in NSCLC With Central Airway Obstruction
NCT06604351Non-Small Cell Lung Cancer
Hunan Province Tumor Hospital
Phase 2
39
Changsha
2024-09-15
Recruiting
Evaluation of the Safety and Effectiveness of Pringle Method Combined With IVC Flow Limiting and Blocking Method in Laparoscopic Hepatectomy Based on Non-restrictive Fluid Therapy Strategy
NCT06594289Liver Tumor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
220
Guangzhou
2024-09-15
Not yet open
Factors Affecting Selection of Leadless Pacemaker and Atrioventricular Synchronous Pacing Status
NCT06587672Pacemaker, Atrioventricular Block, Clinical Trials, Pacing
Xiaohan Fan
Observational
112
Beijing
2024-09-15
Recruiting
SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies
NCT06737081Anemia
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 2
60
Shanghai
2024-09-14
Recruiting
A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in Adults
NCT06783114Upper Limb Spasticity
Chongqing Claruvis Pharmaceutical Co., Ltd.
Phase 2/3
254
Hefei, Beijing, Chongqing, Guangzhou, Shenzhen, Kaifeng, Wuhan, Huai'an
2024-09-14
Recruiting
Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy
NCT07067268Nasopharyngeal Cancinoma (NPC)
Fudan University
Phase 2
76
Shanghai
2024-09-14
Recruiting
Distribution of Mood and Personality Characteristics and Their Influence on Treatment Compliance
NCT07101796Personality, Patient Compliance, Anxiety, Depression
Peking University First Hospital
Observational
200
Beijing
2024-09-14
Recruiting
Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases
NCT06548607SLE (Systemic Lupus), Systemic Sclerosis, ANCA Associated Vasculitis, Idiopathic Inflammatory Myopathies
Nanjing Bioheng Biotech Co., Ltd.
Phase EARLY_PHASE1
20
Bengbu
2024-09-14
Recruiting
Lurbinectedin or in Combination with Irinotecan Versus Topotecan in Patients with Relapsed SCLC
NCT06496048Relapsed Small Cell Lung Cancer
Luye Pharma Group Ltd.
Phase 3
180
Jilin City
2024-09-14
Recruiting
Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer
NCT05578053Breast Cancer
Hebei Medical University Fourth Hospital
Observational
420
Shijiazhuang
2024-09-13
Recruiting
Immune Checkpoint Inhibitors for Organ Preservation in Non-metastatic dMMR/MSI-H Gastric or Colon Cancers
NCT06580574Gastric Cancer, Colon Cancer, MSI-H, DMMR Cancer
Peking University
Phase 2
34
Beijing
2024-09-13
Recruiting
Hyaluronic Acid-enriched Transfer Medium in Single Blastocyst Transfer
NCT06492785Infertility
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
Not applicable
858
Xi'an
2024-09-13
By invitation
Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell Lymphoma
NCT07450040ORR, OS, PFS
Eye & ENT Hospital of Fudan University
Observational
60
Shanghai
2024-09-12
Recruiting
FeNO Detection in Asthma Diagnosis: A New Technology Approach
NCT06852911Bronchial Asthma, Airway Disease
Novlead Inc.
Not applicable
170
Shanghai, Wuxi
2024-09-12
Recruiting
Individualized Exploration of Aerobic Exercise-assisted Treatment of Depression
NCT06594588Depression - Major Depressive Disorder
Peking University
Not applicable
80
Beijing
2024-09-12
Recruiting
Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)
NCT06437977Stage II-III Non-small Cell Lung Cancer
Shanghai Chest Hospital
Phase 3
478
Shanghai
2024-09-12
Recruiting
Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites
NCT06759064Cancer of Stomach, Adenocarcinoma, Ascites, Malignant
Qilu Hospital of Shandong University
Phase 1/2
24
Jinan
2024-09-12
Recruiting
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
NCT06586515Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Colorectal Cancer
Eli Lilly and Company
Phase 1
630
Beijing, Harbin, Shanghai
2024-09-12
Recruiting
Neoadjuvant Immunochemotherapy in PD-L1-negative LACC
NCT06288360Cervical Cancer, Locally Advanced Cervical Cancer, PD-L1 Negative, Neoadjuvant Chemoimmunotherapy
Tongji Hospital
Phase 2
40
Hefei, Beijing, Chongqing, Lanzhou, Nanning, Wuhan, Changsha, Shenyang
2024-09-12
By invitation
A Phase I Clinical Trial to Evaluate CU-10101 Unguent
NCT06744569Atopic Dermatitis
Cutia Therapeutics๏ผˆWuxi๏ผ‰Co.,Ltd
Phase 1
64
Shanghai
2024-09-12
Active, closed
Radiofrequency-responsive Layered Double Hydroxides for Enhanced Arterial Embolization and Thermal Immunotherapy in Hepatocellular Carcinoma
NCT06966986Liver Carcinoma
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Observational
130
Yiwu
2024-09-11
Recruiting
A Study of DC05F01 in Chinese Patients With Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors
NCT06873555Solid Tumors, Ovarian Cancer, Small Cell Lung Cancer
Heronova Pharmaceuticals
Phase 1/2
60
Bengbu, Changsha
2024-09-11
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
NCT06572384Lung Diseases, Interstitial
GlaxoSmithKline
Phase 3
440
Beijing, Chengdu, Guangzhou, Hangzhou, Mianyang, Nanjing, Nanning, Shanghai
2024-09-11
Active, closed
Validation of a Model for Predicting Duodenal Stump Leakage After Gastrectomy
NCT06807372Gastric Cancers
Jichao Qin
Observational
1,200
Hangzhou
2024-09-11
Active, closed
A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)
NCT06487559Hepatocellular Carcinoma (HCC)
AbbVie
Phase 1
3
Beijing, Fuzhou, Guangzhou, Harbin, Zhengzhou, Wuhan, Nanchang, Shenyang
2024-09-11
Recruiting
SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx
NCT06611137Laryngeal Cancer, Hypopharynx Cancer
Sun Yat-sen University
Phase 2
35
Guangzhou
2024-09-11
Recruiting
A Study of the Safety and Tolerability of GA in the Treatment of Patients With Refractory Neuropathic Pain
NCT06596681Pain, Intractable
Beijing Tiantan Hospital
Phase EARLY_PHASE1
6
Beijing
2024-09-11
Recruiting
Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors
NCT06596915Non-Small Cell Lung Cancer, Pancreatic Adenocarcinoma, Breast Cancer, Melanoma
Shandong Boan Biotechnology Co., Ltd
Phase 1
167
Beijing
2024-09-11
Active, closed
Orelabrutinib Followed by Response-adapted Ultra-low Dose 4Gy Radiation as First-line Treatment of MALT Lymphoma
NCT06583837Lymphoma, B-Cell, Marginal Zone
Fudan University
Phase 2
50
Shanghai
2024-09-10
Recruiting
Outcomes for Anesthesiologist-Led Care of Analgesic Protocol in Anorectal Surgery
NCT06015165Postoperative Pain
China-Japan Friendship Hospital
Not applicable
216
Beijing
2024-09-10
Recruiting
Anti-reflux Mucosal Valvuloplasty Versus PPIs for GERD Treatment
NCT06348420Gastroesophageal Reflux Disease
Qilu Hospital of Shandong University
Not applicable
74
Jinan
2024-09-10
Recruiting
Statin Combined with Amlodipine Treats Primary Aldosteronism
NCT06523465Primary Aldosteronism, Statin, Mineralocorticoid Receptor Antagonist, Hypertension
Third Military Medical University
Phase 4
180
Chongqing
2024-09-10
Recruiting
Early Screening Cohort Study of Multiple Gastrointestinal Tumors
NCT07106424Early Detection of Cancer
Shandong Cancer Hospital and Institute
Observational
4,000
Jinan
2024-09-10
Recruiting
Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients
NCT06682156Newly Diagnosed Multiple Myeloma
The First Affiliated Hospital of Soochow University
Observational
50
Suzhou
2024-09-10
Recruiting
Comparison Capsule Sparing Cystectomy and Radical Cystoprostatectomy in Men with Bladder Cancer
NCT05067101Bladder Cancer
Zhujiang Hospital
Not applicable
126
Guangzhou
2024-09-10
Not yet open
Thermal Ablation Vs Thyroidectomy for Large Benign Thyroid Nodules
NCT06607133Benign Thyroid Nodules
Ming-an Yu
Observational
300
Beijing
2024-09-10
Not yet open
A Study of Anti-PD-1 and LAG-3 Bispecific Antibody(AK129) Combined With Chemotherapy With or Without Cadonilimab in the First-line Treatment of Unresectable Locally Advanced or Metastatic G/ GEJ Adenocarcinoma
NCT06586294Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Akeso
Phase 1/2
294
Hanzhou
2024-09-10
Recruiting
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer
NCT06532799Stomach Cancer, Stomach Cancer Recurrent, Stomach Cancer, Adenocarcinoma, Esophageal Cancer
Essen Biotech
Phase 1/2
75
Beijing
2024-09-10
Recruiting
Phase II Clinical Trial of PD-L1 in Combination With Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy With or Without Radiotherapy for Advanced Triple-negative Breast Cancer.
NCT06771609Advanced Triple-negative Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
150
Beijing
2024-09-10
Recruiting
Postoperative Complications Following Skull Base Tumor Resection
NCT06587906Skull Base Tumor, Postoperative Complications
Beijing Tiantan Hospital
Observational
122
Beijing
2024-09-10
Active, closed
To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of Treatment
NCT06500494Advanced Breast Cancer
Pierre Fabre Medicament
Observational
368
Tianjin
2024-09-10
Recruiting
Adebrelimab and Chidamide for Pancreatic Cancer
NCT06584227Pancreatic Cancer, Adult
Liu Xiufeng
Phase 2
45
Nanjing
2024-09-10
Recruiting
Efficacy and Safety of SR1375 in Adult Patients With CAP
NCT06577558Community-acquired Pneumonia
Shanghai SIMR Biotechnology Co., Ltd.
Phase 2
240
Fuyang, Beijing, Zhangzhou, Gaozhou, Guangzhou, Shantou, Yulin, Shijiazhuang
2024-09-10
Recruiting
Safety and Efficacy of RIC in Pediatric Moyamoya Disease Patients Treated With Revascularization Therapy
NCT03546309Moyamoya Disease, Pediatric
Capital Medical University
Not applicable
42
Beijing
2024-09-10
Recruiting
TACE With Thermosensitive Nanogel Versus Embosphere for HCC
NCT06593964Unresectable Hepatocellular Carcinoma
Zhongda Hospital
Not applicable
188
Nanjing
2024-09-10
Recruiting
Optimization of Keverprazan-amoxicillin Dual Therapy for Eradicating Helicobacter Pylori Infection
NCT06734260Helicobacter Pylori Eradication Rate
Eighth Affiliated Hospital, Sun Yat-sen University
Phase 3
477
Guangzhou, Puning, Shenzhen, Xiangyang
2024-09-10
Active, closed
Effect Evaluation of Different Blood Products Infusion on Neonatal Anemia
NCT06285604Neonatal Anemia
Women's Hospital School Of Medicine Zhejiang University
Observational
200
Hangzhou
2024-09-10
Recruiting
Basilar Artery Occlusion Chinese Endovascular Trial in the Extended Time Window
NCT06560203Acute Ischemic Stroke, Basilar Artery Occlusion
Capital Medical University
Not applicable
309
Beijing
2024-09-10
Recruiting
A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer
NCT06692166Cervical Cancer
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 3
420
Beijing, Shanghai
2024-09-10
Recruiting
Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China
NCT07113808Abdominal Neoplasm, Abdominal Injury, Ascites
The Children's Hospital of Zhejiang University School of Medicine
Observational
108
Hangzhou
2024-09-10
Recruiting
FAPI Imaging Assessment of Chronic Total Occlusion
NCT06655922Chronic Total Occlusion (CTO)
Lin Zhao
Observational
167
Beijing
2024-09-10
By invitation
Comparison of 6F and 7F Sheaths for Coronary Intervention Via Distal Radial Artery Access
NCT06585917PCI, Coronary Arterial Disease (CAD)
China National Center for Cardiovascular Diseases
Not applicable
574
Beijing
2024-09-10
Recruiting
Observation of Exhaled VOC Biomarkers Characteristics in Admitted Women with Breast Ultrasound BI-RADS 4 Grade
NCT06489158Breast Cancer
Peking Union Medical College Hospital
Observational
168
Beijing
2024-09-09
Recruiting
Vision Therapy Versus Prism Treatment in Small-angle Acute Acquired Concomitant Esotropia
NCT06622044Esotropia
Eye & ENT Hospital of Fudan University
Not applicable
100
Shanghai
2024-09-07
Recruiting
Exploring the Efficacy, Safety and Cost-effectiveness Analysis of Cadonilimab in the Treatment of Cervical Cancer
NCT06140589Cervical Cancer
Fujian Cancer Hospital
Observational
200
Fuzhou
2024-09-07
Recruiting
Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
NCT06577519Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Jiangsu vcare pharmaceutical technology co., LTD
Phase 3
1,000
Shenyang
2024-09-06
Recruiting
A Study Comparing Laparoscopic/Robotic Stoma Reduced-Port Fusion Surgery with Traditional Surgery in Patients with Temporary Ileostomy
NCT06604052Ileostomy
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
80
Shanghai
2024-09-06
Recruiting
Investigating the Insulin Resistance in Individuals With Type 2 Diabetes
NCT06428968Type 2 Diabetes
Central South University
Not applicable
30
Changsha
2024-09-06
Recruiting
Pinoxin for the Prevention of Radiation-Induced Skin Injury
NCT07545720Cancer Patients Undergoning Radiotherapy
Fudan University
Phase 2
202
Shanghai
2024-09-05
Recruiting
Online Adaptive Radiotherapy for Cervical Cancer
NCT06562166Cervical Cancer
Peking Union Medical College Hospital
Phase 2
124
Beijing
2024-09-05
Recruiting
Radiomics for Preoperative Jaw Cyst Differentiation
NCT06579768Jawbone Cysitc Lesion
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
300
Guangzhou
2024-09-05
Recruiting
ICAS Screen Based on RIC
NCT06610578Intracranial Atherosclerosis
Xuanwu Hospital, Beijing
Observational
2,100
Beijing
2024-09-05
Recruiting
The Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric Cancer
NCT06786169Gastric Cancer, Gastroesophageal Junction Cancer
Fudan University
Observational
600
Shanghai
2024-09-05
Recruiting
Efficacy and Mechanism of rTMS on the Symptoms of Pleasure Deficit in Adolescent Depression
NCT06580249Depression
Xijing Hospital
Not applicable
44
Xi'an
2024-09-05
Recruiting
A Study to Evaluate CG-105-12 in Patients With Relapsed/Refractory Multiple Myeloma
NCT06999031Relapsed/Refractory, Multiple Myeloma
The First Affiliated Hospital of Nanchang University
Phase EARLY_PHASE1
12
Nanchang
2024-09-05
Active, closed
Onco-Respirology Epidemiology Based on Real-world Big Data in Respiratory Medicine
NCT06670560Respiratory, Epidemiology, Neoplasms
Zhou Chengzhi
Observational
100,000
Guangdong
2024-09-05
Rows per page Showing 11501–11600 of 19052
Previous 114 115 116 117 118 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=116

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.